Cite
HARVARD Citation
Malangone-Monaco, E. et al. (n.d.). Real-world treatment patterns, adverse events (AEs) and outcomes associated with Bacillus Calmette-Guerin (BCG) use for non-muscle invasive bladder cancer (NMIBC) in the United States. European journal of cancer. pp. S191-. [Online].